Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultragenyx Pharmaceutical Inc. (Ultragenyx or 'the company') is a clinical-stage bio-pharmaceutical company. The company classifies its business in a single business: the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company's marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products including, DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency; and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). The company through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, Netherlands, France, Colombia, Canada and Mexico. Ultragenyx is headquartered in Novato, California, the US.

Scope

– Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments

– Intelligence on Ultragenyx Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Ultragenyx Pharmaceutical Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Ultragenyx Pharmaceutical Inc.: Company Overview

Ultragenyx Pharmaceutical Inc.: Overview and Key Facts

Ultragenyx Pharmaceutical Inc.: Overview

Ultragenyx Pharmaceutical Inc.: Key Facts

Ultragenyx Pharmaceutical Inc.: Key Employees

Ultragenyx Pharmaceutical Inc.: Key Employee Biographies

Ultragenyx Pharmaceutical Inc.: Major Products and Services

Ultragenyx Pharmaceutical Inc.: Company History

Ultragenyx Pharmaceutical Inc.: Management Statement

Ultragenyx Pharmaceutical Inc.: Key Competitors

Ultragenyx Pharmaceutical Inc.: Company Analysis

Ultragenyx Pharmaceutical Inc.: Business Description

Ultragenyx Pharmaceutical Inc.: SWOT Analysis

Ultragenyx Pharmaceutical Inc.: SWOT Overview

Ultragenyx Pharmaceutical Inc.: Strengths

Ultragenyx Pharmaceutical Inc.: Weaknesses

Ultragenyx Pharmaceutical Inc.: Opportunities

Ultragenyx Pharmaceutical Inc.: Threats

Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity

Ultragenyx Pharmaceutical Inc.: Financial Deals Overview

Ultragenyx Pharmaceutical Inc.: Targets and Partners

Ultragenyx Pharmaceutical Inc.: Top Deals 2017 - 2021YTD*

Ultragenyx Pharmaceutical Inc.: Advisors

Ultragenyx Pharmaceutical Inc.: Top Legal Advisors

Ultragenyx Pharmaceutical Inc.: Top Financial Advisors

Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions

Ultragenyx Pharmaceutical Inc.: Capital Raising

Ultragenyx Pharmaceutical Inc.: Partnership

Ultragenyx Pharmaceutical Inc.: Divestments

Ultragenyx Pharmaceutical Inc.: Recent Developments

Ultragenyx Pharmaceutical Inc.: News and Events Summary

Ultragenyx Pharmaceutical Inc.: Business Expansion

Ultragenyx Pharmaceutical Inc.: Corporate Governance

Ultragenyx Pharmaceutical Inc.: Financial Performance

Ultragenyx Pharmaceutical Inc.: Market Developments

Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events

Ultragenyx Pharmaceutical Inc.: Research & Development

Ultragenyx Pharmaceutical Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts

Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees

Table 3: Ultragenyx Pharmaceutical Inc.: Company History

Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors

Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Table 7: Ultragenyx Pharmaceutical Inc.: M&A Average Deal Size – Value (US$m)

Table 8: Ultragenyx Pharmaceutical Inc.: Targets and Partners

Table 9: Ultragenyx Pharmaceutical Inc.: Top Deals 2017 – 2021YTD*

Table 10: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)

Table 11: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)

Table 12: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2017 – YTD*2021)

Table 13: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2017 – YTD*2021)

Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2017 – YTD*2021)

Table 15: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2017 – YTD*2021)

Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2017 – YTD*2021)

Table 17: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2017 – YTD*2021)

Table 18: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2017 – YTD*2021)

Table 19: Ultragenyx Pharmaceutical Inc.: News and Events Summary

Table 20: Ultragenyx Pharmaceutical Inc.: Business Expansion

Table 21: Ultragenyx Pharmaceutical Inc.: Corporate Governance

Table 22: Ultragenyx Pharmaceutical Inc.: Financial Performance

Table 23: Ultragenyx Pharmaceutical Inc.: Market Developments

Table 24: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events

Table 25: Ultragenyx Pharmaceutical Inc.: Research & Development

Table 26: Ultragenyx Pharmaceutical Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Figure 3: Ultragenyx Pharmaceutical Inc.: M&A Average Deal Size – Value (US$m)

Figure 4: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2017 – YTD*2021)

Figure 5: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2017 – YTD*2021)

Figure 6: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2017 – YTD*2021)

Figure 7: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2017 – YTD*2021)

Figure 8: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2017 – YTD*2021)

Figure 9: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2017 – YTD*2021)

Figure 10: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2017 – YTD*2021)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2745

Saved reports